B2M and inclusion body myositis: By qRT-PCR, we were able to confirm the sequencing data by showing significant up-regulation in expression of CD74, β2-microglobulin (B2M) and insulin growth factor 2 (IGF2) in both Jo-1 and IBM (Fig. 2b).